Journal
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Volume 156, Issue 2, Pages E41-E74Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2018.02.115
Keywords
-
Funding
- Edwards Lifesciences
- Medtronic
- St Jude Medical
- CryoLife
Ask authors/readers for more resources
Bicuspid aortic valve disease is the most common congenital cardiac disorder, being present in 1% to 2% of the general population. Associated aortopathy is a common finding in patients with bicuspid aortic valve disease, with thoracic aortic dilation noted in approximately 40% of patients in referral centers. Several previous consensus statements and guidelines have addressed the management of bicuspid aortic valve-associated aortopathy, but none focused entirely on this disease process. The current guidelines cover all major aspects of bicuspid aortic valve aortopathy, including natural history, phenotypic expression, histology and molecular pathomechanisms, imaging, indications for surgery, surveillance, and follow-up, and recommendations for future research. It is intended to provide clinicians with a current and comprehensive review of bicuspid aortic valve aortopathy and to guide the daily management of these complex patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available